Prenetics (NASDAQ:PRE), a leading genomics-driven health sciences company, is revolutionizing prevention, early detection, and treatment. Our prevention arm, CircleDNA, uses whole exome sequencing to offer the world's most comprehensive consumer DNA test. Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, underscores our unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Lastly, ACT Genomics, our treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances our global impact on health, truly embodying our commitment to enhancing life through science.
View Top Employees from PreneticsWebsite | https://prenetics.com/ |
Revenue | $34 million |
Funding | $52.6 million |
Employees | 387 (387 on RocketReach) |
Founded | 2014 |
Phone | +852 2210 9588 |
Industry | Biotechnology, Biotechnology Research, Business Services General, DNA Testing, Business Services, Science and Engineering, Other Healthcare Services, Personalized Medicine, Genetics, Pharmacogenomics Testing, Health Care, Health & Wellness, Life Science |
Web Rank | 4 Million |
Keywords | Dna Analysis, Population Health, Molecular Diagnostics |
Competitors | 23andMe, Pathway Genomics Corporation, PreventionGenetics, Sema4, Veritas Genetics |
SIC | SIC Code 80 Companies, SIC Code 807 Companies |
NAICS | NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Prenetics employee's phone or email?
The Prenetics annual revenue was $34 million in 2024.
Senthil Sundaram is the Chief Clinical Officer of Prenetics.
387 people are employed at Prenetics.
The NAICS codes for Prenetics are [62151, 6215, 621, 62].
The SIC codes for Prenetics are [80, 807].